Table of contents
January 2003 Vol 2 No 1
- Research Highlights
- News and Analysis
- Focus on: Atherothrombosis
- Reviews
- Perspectives
- Careers and Recruitment
Also this month:
- Article series: A guide to drug discovery
In This Issue
p1 | doi:10.1038/nrd992
Editorial: Guiding drug discovery through 2003
p3 | doi:10.1038/nrd1003
Research Highlights
Obesity: A high dose of JuNK for fat mice
p5 | doi:10.1038/nrd993
Biotechnology: Putting a finger on gene expression
p6 | doi:10.1038/nrd994
Muscular degeneration: Body building best without myostatin
p6 | doi:10.1038/nrd995
Amyloid diseases: Assembly instructions
p7 | doi:10.1038/nrd996
Nsaids: Better design through chemistry
p8 | doi:10.1038/nrd997
Obesity: It goes straight to my hips
p8 | doi:10.1038/nrd998
In brief
Gene Therapy | Lead Identification | Structure-Based Drug Design
p9 | doi:10.1038/nrd1000
Bone diseases: Leptin bares our bones, sympathetically
p9 | doi:10.1038/nrd999
Patent watch
Pay up for the 21 Century Strategic Plan | No speculation in application
p10 | doi:10.1038/nrd1001
Adrenoceptor pharmacology: Variety is the spice of life
p10 | doi:10.1038/nrd1002
News and Analysis
From the analyst's couch
Antithrombotic drug market
p11 | doi:10.1038/nrd966
Fresh from the Pipeline
Drotrecogin alpha (activated)
p13 | doi:10.1038/nrd991
Focus on: Atherothrombosis
Reviews
Scientific and therapeutic advances in antiplatelet therapy
Deepak L. Bhatt & Eric J. Topol
p15 | doi:10.1038/nrd985
Reviews
Scientific and therapeutic advances in antiplatelet therapy
Deepak L. Bhatt & Eric J. Topol
p15 | doi:10.1038/nrd985
The emerging field of nanotube biotechnology
Charles R. Martin & Punit Kohli
p29 | doi:10.1038/nrd988
Knockouts model the 100 best-selling drugs—will they model the next 100?
Brian P. Zambrowicz & Arthur T. Sands
p38 | doi:10.1038/nrd987
Therapeutic antibodies for human diseases at the dawn of the twenty-first century
Ole Henrik Brekke & Inger Sandlie
p52 | doi:10.1038/nrd984
Article series: A guide to drug discovery
A guide to drug discovery: Target selection in drug discovery
Jonathan Knowles & Gianni Gromo
p63 | doi:10.1038/nrd986
Perspectives
Timeline
The Common Technical Document: the changing face of the New Drug Application
Justina Molzon
p71 | doi:10.1038/nrd990
Outlook
The further evolution of biotech
Tricia Nagle, Carilee Berg, Rena Nassr & Kevin Pang
p75 | doi:10.1038/nrd989
